The world’s hottest pharmaceutical trend didn’t start in Hollywood. It started in the fight against type 2 diabetes. The GLP-1 import scene is continuously growing with drugs like Ozempic, Wegovy, and Zepbound transforming obesity treatment and reshaping global healthcare.
As the GLP-1 import market continues to grow, the industry is projected to exceed $100 million by 2030. Biotech companies are racing to bring their GLP-1 imports to market. Given supply chain demands, GLP-1 imports need to be structured effectively to avoid delays to market.
Biotechs and Obesity Clinical Trials | How We Help GLP-1 imports
TecEx helps biotech companies accelerate global GLP-1 clinical trials through compliant importation, customs expertise, and streamlined logistics. Our global compliance network has enabled a 46% reduction in the time required to secure import licenses across key regions, helping sponsors maintain timelines and avoid costly delays.
Through our bespoke global logistics and customs compliance solution, we enable the deployment of clinical trial commodities to clinical trial sites across the globe.
With obesity trials taking place globally and recognizing that each country has unique customs compliance variations, regulatory approval processes, and country-specific nuances, TecEx Medical can assist you with importing clinical trial goods to any location.
Relax knowing your GLP-1 import will arrive compliantly, efficiently, and on time.
Let TecEx act as your obesity trial project manager, enabling compliant and efficient global clinical trials for GLP-1 and obesity drugs.
Accelerating GLP-1 Imports for Clinical Trials
The weight-loss drug market exploded, but, as with any emerging drug, the future belongs to those who get there first. This means leveraging service providers that can simplify your clinical trial GLP-1 imports. Aspects of trials, such as VAT optimization, global compliance, and Importer of Record solutions, are vital to clinical trial rollouts – ensuring smooth, efficient clinical trial distribution.
For biotech companies, meeting clinical trial timelines and site initiation visit (SIV) dates is essential. Any delay in GLP-1 import approvals, customs clearance, or country-specific compliance can derail the study, delay regulatory milestones, and result in lost revenue.
Running global GLP-1 import drug trials for obesity is already complex. Sponsors should not also have to manage the risks of importing clinical trial materials in their own name.
TecEx helps biotech companies accelerate global GLP-1 clinical trials through compliant importation, customs expertise, and streamlined logistics. Our global compliance network has enabled a 46% reduction in the time required to secure import licenses across key regions, helping sponsors maintain timelines and avoid costly delays.
Relax knowing your GLP-1 import will arrive compliantly, efficiently, and on time.
Let TecEx act as your trial project manager to enable compliant, efficient global clinical trials for GLP-1 and obesity drugs.
GLP-1 Clinical Trial Commodities We Import
Clinical trials are more than just the drug being tested. Many additional products must be shipped to the various trial sites. These products must be imported correctly and compliantly, leading to significant administrative work and compliance research to ensure customs clears the goods. The same goes for GLP-1 imports.
As you can see, having a specialist clinical trial IOR can help you clear customs efficiently and effectively, and get your goods to the site before SIV.
Get ahead of your competitors with TecEx Medical and enter the market with compliant and efficient GLP-1 imports.
Why GLP-1 Therapies Matter? | The Obesity Crisis
The global health landscape is facing a growing crisis: obesity. Numbers are on a relentless upward trend, impacting millions of lives worldwide. This surge in weight-related issues has fueled a new wave of research and development – and given rise to new weight-loss drugs. Furthermore, this has led to an increase in GLP-1 imports.
The obesity epidemic is a major global health concern, with numbers steadily rising. Here are some key statistics:
Global Impact
It’s estimated that over 1 billion people worldwide are living with obesity, including nearly 880 million adults and 159 million children.
Dramatic Increase
Since 1975, obesity rates in adults have nearly tripled for women and quadrupled for men.
Overweight Included
When including overweight individuals, the number jumps to 2.5 billion adults, with 43% of adults globally classified as overweight or obese.
With obesity numbers reaching unprecedented levels, the need for effective solutions is more pressing than ever. Traditional methods like diet and exercise haven’t always yielded the desired results for everyone. The pivot to weight-loss medications comes from the significant traction being offered by these drugs in the war against obesity.
The explosive growth of the GLP-1 weight-loss market has turned the race for market entry into a high-stakes competition for biotech companies. By acting as a specialized Importer of Record, TecEx Medical reduces import license lead times by 46% and absorbs customs risks. Don’t let customs compliance delay GLP-1 imports, TecEx Med is there to assist type of thing.
